2010年

1. ・ Design and Synthesis of Indole Derivatives of Adenophostin A. A Entry into Subtype-Selective IP3 Receptor Ligands. T. Mochizuki, A. Tanimura, A. Nezu, M. Ito, H. Abe, Y. Ito, M. Arisawa, S. Shuto, Tetrahedron Lett., 2010, 51, 977-979.
   


2. ・ Synthesis and Structural and Pharmacological Properties of Cyclopropane-Based Conformationally Restricted Analogs of 4-Methylhistamine as Histamine H3/H4 Receptor Ligands. T. Kobayashi, M. Watanabe, A. Yoshida, S. Yamada, M. Ito, H. Abe, Y. Ito, M. Arisawa, S. Shuto, Bioorg. Med. Chem., 2010, 18, 1076-1082.
   


3. ・ Investigation of the Bioactive Conformation of Histamine H3 Receptor Antagonists by the Cyclopropylic Strain-Based Conformational Restriction Strategy. M. Watanabe, T. Hirokawa, T. Kobayashi, A. Yoshida, Y. Ito, S. Yamada, N. Orimoto, Y. Yamasaki, M. Arisawa, S. Shuto, J. Med. Chem., 2010, 53, 3585-3593.
   


4. ・ Sulfur Modification of Au via Treatment with Piranha Solution Provides Low-Pd releasing and recyclable Pd Material, SAPd. N. Hoshiya, M. Shimoda, H. Yoshikawa, Y. Yamashita, S. Shuto, M. Arisawa, J. Am. Chem. Soc. 2010, 132, 7270-7272.
   


5. ・ A. Ishii, H. Asano, M. Yokoyama, S. Tsukamoto, S. Shuto, M. Arisawa, Structure determination of Pd-catalyst supported on S-terminated GaAs(001) using DFT calculation. Physica Status Solidi C: Current Topics in Solid State Physics, 2010, 7, 359-361.
   


6. ・ M. Shimoda, T. Konishi, K. Tateishi, T. Toujyou, S. Tsukamoto, N. Nishiwaki, M. Arisawa, N. Hoshiya, S. Shuto, N. Isomura, H. Yokota, Y. Furukawa, K. Iizuka, T. Ogiwara, Y. Isozaki, Y. Yamashita, H. Yoshikawa, S. Ueda, K. Kobayashi, J. Appl. Phy., 2010,108, 024309 1-5.
   

その他の総説等

1. ・ 有澤光弘，星谷尚亨，周東　智、創薬研究支援を指向した基板担持型パラジウムの開発，有合化, 2010, 68, 920-929